HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma with a CD15(+)CD30(-) phenotype.

Abstract
Primary cutaneous aggressive epidermotropic CD8(+) T-cell lymphoma (CD8(+)TCL) is an extremely rare entity with distinct clinicopathological features. While the CD15 antigen is typically associated with classic Hodgkin's lymphoma, aggressive peripheral T-cell lymphomas, including advanced stage cutaneous T-cell lymphomas, rarely express this molecule. We report a case of primary cutaneous aggressive epidermotropic CD8(+)TCL, in which lymphoma cells are CD15(+)CD30(-) with a medium-to-large pleomorphic phenotype. Although the functional characteristics of CD15 expression in the cutaneous lymphomas are not fully understood, the poor prognosis of primary cutaneous aggressive epidermotropic CD8(+)TCL might be associated with the presence of this molecule in our case.
AuthorsNaho Yoshizawa, Hiroaki Yagi, Takahiro Horibe, Masahiro Takigawa, Makoto Sugiura
JournalEuropean journal of dermatology : EJD (Eur J Dermatol) 2007 Sep-Oct Vol. 17 Issue 5 Pg. 441-2 ISSN: 1167-1122 [Print] France
PMID17673391 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Ki-1 Antigen
  • Lewis X Antigen
Topics
  • Aged
  • CD8-Positive T-Lymphocytes (immunology)
  • Flow Cytometry
  • Humans
  • Immunohistochemistry
  • Ki-1 Antigen (analysis)
  • Lewis X Antigen (analysis)
  • Lymphoma, T-Cell, Cutaneous (diagnosis, immunology)
  • Male
  • Prognosis
  • Skin Neoplasms (diagnosis, immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: